Pierre Lévy

Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19

Violaine Guérin, Pierre Lévy, Jean-Louis Thomas, Thierry Lardenois, Philippe Lacrosse, Emmanuel Sarrazin, Natacha Regensberg-de Andreis & Martine Wonner · Asian Journal of Medicine and Health · 2020

Aims: The challenge regarding COVID-19 is to prevent complications and fatal evolution. Azithromycin (AZM) and hydroxychloroquine (HCQ) have proven their antiviral effect in vitro. We aimed to assess the efficacy and safety of AZM alone or combined to HCQ, prescribed, at an early...

Open access Research Article 10.9734/ajmah/2020/v18i730224

Cost Effectiveness of Intermittent Preventive Treatment of Malaria in Infants in Ghana

Anselm Komla Abotsi, Ebenezer Inkoom, Eric Ribaira, Rozenn Le Mentec, Pierre Lévy, Herve Lafarge & Alexandra de Sousa · International Journal of TROPICAL DISEASE & Health · 2012

Aim: In order to integrate malaria Intermittent Preventive Treatment in infants (IPTi) into the Ghana national immunization programme, there was the need to evaluate the feasibility of IPTi by assessing the intervention operational issues including its implementation costs, and i...

Open access Research Article 10.9734/IJTDH/2012/1017